BRIEF published on 12/09/2024 at 09:00, 1 year 9 months ago CEO Andreas Wegerich Initiates Partial Management Buy-Out at Nakiki SE Investment Strategy NAKIKI SE Corporate Growth Andreas Wegerich Management Buy-Out
PRESS RELEASE published on 12/09/2024 at 08:55, 1 year 9 months ago Partial Management Buy-Out by CEO Andreas Wegerich CEO Andreas Wegerich of Nakiki SE plans a partial management buy-out, acquiring up to 29% of company shares for long-term growth and strategic development Strategic Growth NAKIKI SE Company Shares Andreas Wegerich Management Buy-Out
BRIEF published on 10/10/2024 at 09:26, 1 year 11 months ago Nakiki SE Signs Letter of Intent for Lawsuit Worth Up to One Million Euros Lawsuit Letter Of Intent Financial Strategy NAKIKI SE Inheritance Determination
PRESS RELEASE published on 10/10/2024 at 09:21, 1 year 11 months ago EQS-Adhoc: Nakiki SE: Letter of Intent for New Lawsuit up to One Million Euros Nakiki SE signs Letter of Intent for financing an inheritance determination lawsuit up to 1 million euros, entitled to 33% share of litigation success Financing Lawsuit Letter Of Intent NAKIKI SE Litigation Success
BRIEF published on 10/08/2024 at 13:35, 1 year 11 months ago Nakiki SE Signs Letter of Intent for Lawsuit Financing NAKIKI SE Hamburg Lawsuit Financing Construction Defects Litigation Success
PRESS RELEASE published on 10/08/2024 at 13:30, 1 year 11 months ago EQS-Adhoc: Nakiki SE: Letter of Intent for New Lawsuits (up to EUR 2.4 Million) Nakiki SE signs Letter of Intent for lawsuits financing up to EUR 2.4 million due to construction defects. Entitled to 33% of litigation success Letter Of Intent NAKIKI SE Construction Defects Litigation Success Lawsuits Financing
BRIEF published on 09/21/2024 at 09:53, 1 year 11 months ago Nakiki SE: Mask Lawsuits Will Not Be Financed NAKIKI SE COVID Masks Litigation Funding Legal Matter Supply Contracts
PRESS RELEASE published on 09/21/2024 at 09:48, 1 year 11 months ago EQS-Adhoc: Nakiki SE: Mask lawsuits will not be financed Nakiki SE will not finance 'mask lawsuits' against the government for COVID mask supply contracts after careful evaluation, but remains open to financing such claims NAKIKI SE COVID Masks Litigation Funding Mask Lawsuits Legal Evaluation
BRIEF published on 08/27/2024 at 09:02, 2 years ago Nakiki SE Investigates First Capital Market Claim Worth EUR 400,000 Growth Strategy NAKIKI SE Litigation Financing Securities Law Capital Market Claim
PRESS RELEASE published on 08/27/2024 at 08:57, 2 years ago Nakiki SE: Examination of first capital market claim Nakiki SE explores capital market claim for potential litigation financing, expanding into new business area. With legal experts, aims to maximize plaintiffs' success Investors NAKIKI SE Litigation Financing Legal Protection Capital Market Claim
Published on 09/18/2026 at 06:30, 1 hour 48 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 7 hours 23 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 7 hours 53 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 10 hours 3 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 08:05, 12 minutes ago THE TOKYO PASS Renews Official Website, Redefining Wellness Tourism in Tokyo with "Museum Bathing (R)"
Published on 09/18/2026 at 08:00, 18 minutes ago Gledhow Investments plc: Appointment of Aquis Corporate Adviser
Published on 09/17/2026 at 17:40, 14 hours 38 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 14 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 1 hour ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
